Unknown

Dataset Information

0

Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis.


ABSTRACT:

Objective

We aimed to assess whether individuals at ultra high risk (UHR) for psychosis have higher rates of cannabis use and cannabis use disorders (CUDs) than non-UHR individuals and determine whether UHR cannabis users have more severe psychotic experiences than non-users.

Method

We conducted a meta-analysis of studies reporting cannabis use in the UHR group and/or positive or negative symptoms among UHR cannabis users and non-users. Logit event rates were calculated for cannabis use, in addition to odds ratios to assess the difference between UHR and controls. Severity of clinical symptoms in UHR cannabis users and non-users was compared using Hedges' g.

Results

Thirty unique studies were included (UHR n = 4205, controls n = 667) containing data from cross-sectional and longitudinal studies, and randomised control trials. UHR individuals have high rates of current (26.7%) and lifetime (52.8%) cannabis use, and CUDs (12.8%). Lifetime use and CUDs were significantly higher than controls (lifetime OR: 2.09; CUD OR: 5.49). UHR cannabis users had higher rates of unusual thought content and suspiciousness than non-users.

Conclusion

Ultra high risk individuals have high rates of cannabis use and CUDs, and cannabis users had more severe positive symptoms. Targeting substance use during the UHR phase may have significant benefits to an individual's long-term outcome.

SUBMITTER: Carney R 

PROVIDER: S-EPMC5484316 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis.

Carney R R   Cotter J J   Firth J J   Bradshaw T T   Yung A R AR  

Acta psychiatrica Scandinavica 20170207 1


<h4>Objective</h4>We aimed to assess whether individuals at ultra high risk (UHR) for psychosis have higher rates of cannabis use and cannabis use disorders (CUDs) than non-UHR individuals and determine whether UHR cannabis users have more severe psychotic experiences than non-users.<h4>Method</h4>We conducted a meta-analysis of studies reporting cannabis use in the UHR group and/or positive or negative symptoms among UHR cannabis users and non-users. Logit event rates were calculated for cannab  ...[more]

Similar Datasets

| S-EPMC4107098 | biostudies-literature
| S-EPMC5357699 | biostudies-literature
| S-EPMC4624797 | biostudies-literature
| S-EPMC3122277 | biostudies-other
| S-EPMC5514297 | biostudies-other
| S-EPMC8144430 | biostudies-literature
| S-EPMC5605267 | biostudies-literature
| S-EPMC4534425 | biostudies-literature
| S-EPMC5049522 | biostudies-literature
| S-EPMC5814820 | biostudies-other